Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The Journal of Rheumatology|April 1, 2000
Neonatal lupus erythematosus in tripletsY Yazici, K Onel, L SammaritanoLupus|November 26, 2009
Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information?D Erkan, M Barbhaiya, D George, et al.Arthritis and Rheumatism|March 23, 2000
Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndromeN Guballa, L Sammaritano, S Schwartzman, et al.Rheumatology (Oxford, England)|August 3, 2002
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndromeD Erkan, Y Yazici, M G Peterson, et al.Arthritis and Rheumatism|April 1, 1990
Characteristics of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal deathT Qamar, R A Levy, L Sammaritano, et al.Annals of the Rheumatic Diseases|February 26, 2005
Real world experience with antiphospholipid antibody tests: how stable are results over time?D Erkan, W J M Derksen, V Kaplan, et al.The American Journal of Cardiology|March 7, 2001
Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndromeM J Roman, J E Salmon, R Sobel, et al.Arthritis and Rheumatism|February 12, 2004
Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scaleG Ruiz-Irastorza, M A Khamashta, C Gordon, et al.The Journal of Frailty & Aging|July 26, 2023
Association of Baseline Frailty with Patient-Reported Outcomes in Systemic Lupus Erythematosus at 1 YearS B Lieber, M Nahid, M Rajan, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Can women with systemic lupus erythematosus safely use exogenous estrogens?J P Buyon, K C Kalunian, M L Skovron, et al.Pageof 2